Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Paris › NPI 1760546782
Clinic

Hospital & Medical Foundation of Paris, INC.

Hospital & Medical Foundation of Paris, INC. was paid $3.11M by Medicaid between May 2018 and Dec 2024, across 40 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 100% of everything it billed.

33Billing provider infoHOSPITAL & MEDICAL FOUNDATION OF PARIS, INC.
PARIS, IL 61944
33aNPI1760546782assigned 12/21/2006
33bProvider typeRadiology Clinic/Center
28Total paid$3.11M
24GClaims111,149
24DCodes billed40
24AFirst – last monthMay 2018 – Dec 2024
Compared with peers

Next to other Radiology Clinic/Center providers in Illinois

Rank by total paid#1 of 19
Median peer was paid$48K
This provider vs. median64×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201816$0.00
20192,585$81K
202016,044$488K
202124,192$570K
202223,497$665K
202325,296$713K
2024incomplete19,519$598K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 100% 34,424 26,877 $3.11M
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 5,723 4,862 $105.99
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 3,006 2,451 $62.60
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 7,527 6,446 $31.40
81002 <1% 1,336 1,156 $2.60
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 15 13 $0.15
81025 0% 967 859 $0.00
4013F 0% 207 171 $0.00
3078F 0% 1,740 1,495 $0.00
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 0% 448 393 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 135 117 $0.00
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 0% 2,421 2,061 $0.00
28 more codes
17110 0% 59 $0.00
3077F 0% 97 $0.00
J1050 Injection, medroxyprogesterone acetate, 1 mg 0% 12 $0.00
99204 Doctor's office visit, new patient (more involved) 0% 31 $0.00
3725F 0% 13 $0.00
1036F 0% 5,308 $0.00
1034F 0% 1,499 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 0% 12 $0.00
3008F 0% 10,981 $0.00
2000F 0% 506 $0.00
3079F 0% 998 $0.00
99214 Doctor's office visit, returning patient (more involved) 0% 8,831 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 0% 366 $0.00
3074F 0% 2,261 $0.00
3080F 0% 94 $0.00
3075F 0% 372 $0.00
99213 Doctor's office visit, returning patient (routine) 0% 18,848 $0.00
87428 0% 1,780 $0.00
4008F 0% 53 $0.00
J1885 Injection, ketorolac tromethamine, per 15 mg 0% 72 $0.00
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 0% 110 $0.00
87807 0% 618 $0.00
J0561 Injection, penicillin g benzathine, 100,000 units 0% 33 $0.00
4010F 0% 43 $0.00
1035F 0% 110 $0.00
11102 0% 16 $0.00
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 0% 27 $0.00
1000F 0% 50 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialADAMS, MARTIN (VP OF FINANCE & CFO)
Same official

Other billing entities under ADAMS, MARTIN

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.